Notice on Convening the 2024 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Beijing Tiantan Biological Products Corporation Limited on 6ix
Earlier from Beijing Tiantan Biological Products
- Announcement on Preliminary Earnings Estimate for Q1 2025
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Subsidiary Re-obtaining High-tech Enterprise Certificate
- Announcement on Progress in Drug Clinical Trials of Subsidiary
- Announcement on the Change of Sponsor Representative for Continuous Supervision
Later from Beijing Tiantan Biological Products
- Announcement on Convening 2024 Annual Performance and Cash Dividend Meeting
- Announcement on Postponement of 2024 Annual General Meeting
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Subsidiary Obtaining Notice of GMP Compliance Inspection
Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.
Follow Beijing Tiantan Biological Products